Finance

Beta
Lists
BRTX:NASDAQ
BioRestorative Therapies Inc
$0.40
-2.24%
(-0.0093) 1D
$0.40
-1.23% (-0.0050)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRTX...
Open
$0.42
High
$0.42
Low
$0.39
Mkt. cap
10.43M
Avg. vol.
20.78M
Volume
1.37M
52-wk high
$2.04
52-wk low
$0.16
EPS
-$1.09
Beta
0.58
Shares outstanding
25.48M
No. of employees
14
Open
$0.42
High
$0.42
Low
$0.39
Mkt. cap
10.43M
Avg. vol.
20.78M
Volume
1.37M
52-wk high
$2.04
52-wk low
$0.16
EPS
-$1.09
Beta
0.58
Shares outstanding
25.48M
No. of employees
14
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to BRTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for BRTX in the last 3 months.
Highest
Current $0.40
$15.00 (+3,603.70%)
Average
$8.00 (+1,875.31%)
Lowest
$1.00 (+146.91%)
News stories
From sources across the web
About BioRestorative Therapies Inc
CEO-
Employees14
Founded1997
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
303.30K
11.80K
19.60K
23.17K
Cost of goods sold
8.73K
10.57K
1.64K
7.38K
Cost of revenue
8.73K
10.57K
1.64K
7.38K
Research and development expenses
2.23M
2.59M
2.63M
1.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.37M
1.12M
1.22M
1.48M
Operating expense
3.60M
3.71M
3.84M
3.40M
Total operating expenses
3.61M
3.72M
3.84M
3.41M
Operating income
-3.31M
-3.71M
-3.83M
-3.39M
Other non operating income
575.11K
612.99K
583.08K
1.23M
EBT including unusual items
-2.66M
-3.04M
-3.21M
-2.15M
EBT excluding unusual items
-2.66M
-3.04M
-3.21M
-2.15M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.66M
-3.04M
-3.21M
-2.15M
Net profit margin
-875.79%
-25,748.11%
-16,365.49%
-9,298.25%
Earnings per share
-0.30
-0.33
-0.32
-0.12
Interest and investment income
73.92K
57.74K
34.59K
5.48K
Interest expense
-
-
-
-
Net interest expenses
73.92K
57.74K
34.59K
5.48K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.25M
-3.66M
-3.77M
-3.33M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more